3D model is for representation purpose only.
.
.
SRRARRSPRHLGSGC | Doxorubicin |
Identification | |
---|---|
ConjuPepDB ID | cpd01250 |
Smiles | |
Molecular weight | 2220.06 |
Molecular formula | C93H145N33O29S |
Chemical name | Peptide information |
Sequence (one letter) | SRRARRSPRHLGSGC |
Length | 15 |
Peptide name | N/A |
External ID | |
---|---|
CAS number | 916443-68-0 |
Other information | |
---|---|
Application | Antitumor therapy, colon and breast tumors |
Additional function | improved efficacy and circumventing resistance |
Pharmacological class | anticancer |
Conjugate type | sulfide |
Linker | no |
Small molecule | Doxorubicin |
Small molecule CAS | 23214-92-8 |
Structure method | 1H NMR, HPLC |
NMR solvent | DMSO-d6 |
Calculated properties | |
---|---|
LogP | -18.42969 |
Rotatable bonds | 63 |
H bond donor | 39 |
H bond acceptor | 47 |
Polar surface area (PSA) | 1046.64000 |
Citations | |||||
---|---|---|---|---|---|
ID | Title | Year | Authors | Journal | DOI |
Improved Therapeutic Efficacy of Doxorubicin through Conjugation with a Novel Peptide Drug Delivery Technology (Vectocell) | 2006 | Meyer-Losic, Florence; Quinonero, Jerome; Dubois, Vincent; Alluis, Bertrand; Dechambre, Mireille; Michel, Matthieu; Cailler, Francoise; Fernandez, Anne-Marie; Trouet, Andre; Kearsey, Jonathan | Journal of Medicinal Chemistry |